Bank of New York Mellon’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15B Sell
14,694,253
-807,616
-5% -$65.2M 0.19% 96
2026
Q1
$1.34B Sell
15,501,869
-3,609,206
-19% -$346M 0.25% 73
2025
Q4
$1.84B Sell
19,111,075
-2,357,185
-11% -$229M 0.32% 54
2025
Q3
$2.04B Buy
21,468,260
+192,410
+0.9% +$17.7M 0.37% 42
2025
Q2
$1.85B Buy
21,275,850
+595,549
+3% +$50.5M 0.35% 47
2025
Q1
$1.86B Buy
20,680,301
+756,192
+4% +$67.7M 0.37% 45
2024
Q4
$1.59B Sell
19,924,109
-260,916
-1% -$22.6M 0.29% 57
2024
Q3
$1.82B Sell
20,185,025
-810,442
-4% -$68.2M 0.34% 50
2024
Q2
$1.65B Sell
20,995,467
-821,596
-4% -$67.4M 0.31% 56
2024
Q1
$1.9B Buy
21,817,063
+727,931
+3% +$62.1M 0.37% 48
2023
Q4
$1.74B Buy
21,089,132
+696,665
+3% +$53.1M 0.35% 51
2023
Q3
$1.6B Buy
20,392,467
+508,205
+3% +$42.5M 0.35% 48
2023
Q2
$1.75B Sell
19,884,262
-235,809
-1% -$20.3M 0.37% 48
2023
Q1
$1.62B Buy
20,120,071
+534,722
+3% +$43.6M 0.35% 51
2022
Q4
$1.52B Buy
19,585,349
+210,663
+1% +$17.1M 0.35% 56
2022
Q3
$1.56B Buy
19,374,686
+4,816,172
+33% +$433M 0.38% 46
2022
Q2
$1.31B Buy
14,558,514
+624,312
+4% +$63.3M 0.3% 69
2022
Q1
$1.55B Buy
13,934,202
+68,785
+0.5% +$7.27M 0.3% 66
2021
Q4
$1.43B Sell
13,865,417
-1,209,497
-8% -$140M 0.26% 79
2021
Q3
$1.89B Buy
15,074,914
+26,909
+0.2% +$3.48M 0.37% 54
2021
Q2
$1.87B Sell
15,048,005
-4,199,144
-22% -$527M 0.36% 56
2021
Q1
$2.27B Sell
19,247,149
-378,317
-2% -$44.3M 0.46% 38
2020
Q4
$2.3B Buy
19,625,466
+1,527,582
+8% +$168M 0.5% 35
2020
Q3
$1.88B Buy
18,097,884
+291,641
+2% +$29.3M 0.46% 35
2020
Q2
$1.63B Buy
17,806,243
+328,988
+2% +$31.5M 0.44% 42
2020
Q1
$1.58B Buy
17,477,255
+1,035,437
+6% +$110M 0.52% 31
2019
Q4
$1.87B Sell
16,441,818
-542,813
-3% -$59.6M 0.48% 37
2019
Q3
$1.84B Buy
16,984,631
+204,629
+1% +$21.3M 0.51% 34
2019
Q2
$1.63B Sell
16,780,002
-16,798
-0.1% -$1.53M 0.45% 42
2019
Q1
$1.53B Sell
16,796,800
-429,148
-2% -$38.4M 0.43% 44
2018
Q4
$1.57B Buy
17,225,948
+213,593
+1% +$20M 0.49% 38
2018
Q3
$1.67B Buy
17,012,355
+1,276,256
+8% +$118M 0.43% 43
2018
Q2
$1.35B Buy
15,736,099
+1,608,832
+11% +$134M 0.37% 53
2018
Q1
$1.13B Sell
14,127,267
-232,660
-2% -$19.2M 0.31% 65
2017
Q4
$1.16B Sell
14,359,927
-277,143
-2% -$22.2M 0.31% 66
2017
Q3
$1.14B Sell
14,637,070
-61,701
-0.4% -$5.12M 0.31% 67
2017
Q2
$1.3B Sell
14,698,771
-610,637
-4% -$51.5M 0.37% 57
2017
Q1
$1.23B Sell
15,309,408
-617,551
-4% -$48.2M 0.34% 60
2016
Q4
$1.13B Sell
15,926,959
-1,166,490
-7% -$91.6M 0.33% 64
2016
Q3
$1.48B Sell
17,093,449
-1,443,767
-8% -$126M 0.44% 44
2016
Q2
$1.61B Sell
18,537,216
-682,747
-4% -$55.2M 0.49% 35
2016
Q1
$1.44B Buy
19,219,963
+608,171
+3% +$45.8M 0.44% 41
2015
Q4
$1.43B Sell
18,611,792
-887,959
-5% -$66.8M 0.43% 47
2015
Q3
$1.31B Sell
19,499,751
-736,639
-4% -$54.3M 0.4% 51
2015
Q2
$1.5B Sell
20,236,390
-709,706
-3% -$54.2M 0.41% 48
2015
Q1
$1.63B Buy
20,946,096
+4,256,382
+26% +$323M 0.42% 44
2014
Q4
$1.2B Sell
16,689,714
-514,670
-3% -$35.8M 0.31% 63
2014
Q3
$1.07B Sell
17,204,384
-1,081,732
-6% -$68.8M 0.29% 70
2014
Q2
$1.17B Sell
18,286,116
-670,733
-4% -$40.7M 0.31% 63
2014
Q1
$1.17B Buy
18,956,849
+342,804
+2% +$20M 0.32% 62
2013
Q4
$1.07B Sell
18,614,045
-223,609
-1% -$12.7M 0.3% 64
2013
Q3
$1B Sell
18,837,654
-3,423,327
-15% -$184M 0.3% 61
2013
Q2
$1.15B Buy
+22,260,981
New +$1.1B 0.36% 50

Other funds holding MDT

Bank of New York Mellon's MDT Position: Q2 2026 in Review

Bank of New York Mellon reduced its Medtronic (MDT) stake by 5.2% in Q2 2026, selling an estimated $65.2M and leaving 14,694,253 shares worth $1.15B. The position accounts for 0.19% of the portfolio, ranked #96.

Bank of New York Mellon first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.3B in Q4 2020. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bank of New York Mellon held 14,694,253 shares of Medtronic worth $1.15B as of Q2 2026.
  • Bank of New York Mellon sold 807,616 Medtronic shares in Q2 2026, an estimated $65.2M.
  • Medtronic made up 0.19% of Bank of New York Mellon's portfolio in Q2 2026, its #96 holding.
  • Bank of New York Mellon first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Bank of New York Mellon's Medtronic position peaked at $2.3B in Q4 2020.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.